| Literature DB >> 32189010 |
Yaseen M Arabi1,2,3, Srinivas Murthy4, Steve Webb5.
Abstract
The original version of this article unfortunately contained a mistake.Entities:
Year: 2020 PMID: 32189010 PMCID: PMC7087553 DOI: 10.1007/s00134-020-06009-2
Source DB: PubMed Journal: Intensive Care Med ISSN: 0342-4642 Impact factor: 17.440
Comparison between COVID-19 and the other two coronaviruses infections, the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) [4,13–17,26]
| COVID-19 | MERS | SARS | |
|---|---|---|---|
| Epidemiologic links | Wuhan, China | Arabian Peninsula | Guangdong, China |
| Animal host | Unclear, bat suspected | Dromedary camel | Civet cats and bats suspected |
| Human–human transmission | Yes | Yes | Yes |
| Nosocomial transmission | Yes | Yes | Yes |
| Risk to healthcare workers | Yes | Yes | Yes |
| Countries with reported cases | 54 | 27 | 26 |
| Number of cases | 85,403 as of March 1, 2020 | 2494 | 8437 |
| Clinical features of critically ill patients | |||
| Age, years | 60 | 58 | 57 |
| Comorbid conditions | 40% | 80% | ++ |
| ARDS/pneumonia | Main feature | Main feature | Main feature |
| Shock and multiorgan failure | Yes | Yes | Yes |
| Invasive mechanical ventilation | 42% | 85% | 76% |
| Vasopressors | 35% | 79% | 44% |
| Renal replacement therapy | 17% | 49% | 11% |
| Mortality | 62% | 67% | 34% |